CN Stock MarketDetailed Quotes

Harbin Gloria Pharmaceuticals (002437)

Watchlist
  • 3.15
  • -0.03-0.94%
Not Open Mar 26 15:00 CST
7.02BMarket Cap24.05P/E (TTM)

Harbin Gloria Pharmaceuticals (002437) Key Financial Indicators

002437 Earnings per Share (EPS)

According to the latest financial report of Harbin Gloria Pharmaceuticals, the latest earnings per share (TTM) for the company is 0.11. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: CNY

Cumulative Quarterly

Loading...

002437 Book Value Per Share (BVPS)

Analyzing a company's fundamentals? Check out Harbin Gloria Pharmaceuticals's latest financial report to see how much their book value per share (BVPS) is currently at 0.96.

Currency: CNY

Cumulative Quarterly

Loading...

002437 Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Harbin Gloria Pharmaceuticals shows that the company's current ratio is 1.39, indicating healthy liquidity.

Currency: CNY

Cumulative Quarterly

Loading...

002437 Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Harbin Gloria Pharmaceuticals, the quick ratio is 1.21, indicating that the company can meet its short-term debt obligations.

Currency: CNY

Cumulative Quarterly

Loading...

002437 Return on Equity (ROE)

Want to learn more about the financial health of Harbin Gloria Pharmaceuticals? The latest ROE figure is 11.87%, indicating that the company has stable profitability.

Currency: CNY

Cumulative Quarterly

Loading...

002437 Return on Assets (ROA)

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Harbin Gloria Pharmaceuticals, the total asset return on investment (ROA) is 8.47%.

Currency: CNY

Cumulative Quarterly

Loading...

002437 Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check Harbin Gloria Pharmaceuticals's latest financial report to see how their gross margin is doing - currently at 46.42%.

Currency: CNY

Cumulative Quarterly

Loading...

002437 Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Harbin Gloria Pharmaceuticals, the net profit margin is 14.89%, which is a good sign for its profitability.

Currency: CNY

Cumulative Quarterly

Loading...

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
Recently, the prospect of a ceasefire negotiation between the US and Iran has been dominating market sentiment. On March 26 EST, President T Show More